##  [Novartis announces new late-breaking ofatumumab data at EAN underscoring commitment to advancing treatment of relapsing forms of multiple sclerosis (RMS)](/us-en/news/media-releases/novartis-announces-new-late-breaking-ofatumumab-data-ean-underscoring-commitment-advancing-treatment-relapsing-forms-multiple-sclerosis-rms-0 "Novartis announces new late-breaking ofatumumab data at EAN underscoring commitment to advancing treatment of relapsing forms of multiple sclerosis (RMS)") 

  May 27, 2020